Ressources

Persons with chronic pain and women tend to enter treatment for opioid use disorder with greater opioid withdrawal severity than persons without chronic pain and men, respectively.

This study examines associations between social determinants of health (SDoH) and medications for opioid use disorder (MOUD) retention among patients with opioid use disorder (OUD) in rural primary

To explore consumer and pharmacist experiences of OAT services, identifying the social and structural elements that enhance or impair treatment and professional satisfaction and analyzing how these

This study aimed to synthetize the evidence on the effectiveness of harm minimization interventions on reducing blood-borne infection transmission and injecting behaviors among people who inject dr

The aim of this study was to examine the facilitators and barriers to the adoption of Mobile Overdose Response Services (MORS) in Canada.

We aimed to characterise overdose mortality in Toronto, ON, Canada, and to establish the spatial association between supervised consumption services (SCS) locations and overdose mortality events.

Purpose: To provide information on implementation of the provincial Prescribed Safer Supply (PSS) policy, and recommendations to improve benefits and minimize harms.

Previous research suggests that interpersonal relationships moderate treatment outcomes for opioid use disorder based on the nature and quality of the relationship.

To develop a better understanding of the context of drug use, we interviewed safer supply program participants in Ottawa, Canada.

This study utilized qualitative interviews to explore opioid withdrawal experiences and consequences among people who use opioids (PWUO) in Los Angeles County, USA.

This study investigates the effectiveness of a short video targeting pharmacists that addresses implementation barriers for take-home naloxone (THN).

Point-of-care drug checking identifies components of a drug sample and delivers results consumers.

To better identify individuals at risk and inform patients and clinicians about xylazine risk factors.

This study explores treatment experiences of people who use illicit stimulants (PWUS) to identify gaps and perceptions of prospective pharmaceutical stimulant substitution treatments (SST).

This study is the first one which compares patients' self-assessment of the risk of future opioid overdose with the hetero-assessment provided by healthcare professionals in a population of individ